Home/Filings/4/0000850693-07-000025
4//SEC Filing

ALLERGAN INC 4

Accession 0000850693-07-000025

CIK 0000850693operating

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 6:54 PM ET

Size

10.3 KB

Accession

0000850693-07-000025

Insider Transaction Report

Form 4
Period: 2007-01-29
EVANS HANDEL
Director
Transactions
  • Award

    Phantom Stock Units

    2007-01-29$115.91/sh+8.63$1,00028,993.13 total
    Common Stock (0 underlying)
  • Award

    Phantom Stock Units

    2007-01-30$115.87/sh+17.26$2,00029,019.02 total
    Common Stock (0 underlying)
Footnotes (3)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
  • [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.

Documents

1 file

Issuer

ALLERGAN INC

CIK 0000850693

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000850693

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:54 PM ET
Size
10.3 KB